3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Multiple Myeloma
420
Precursor Cell Lymphoblastic Leukemia-Lymphoma
126
Neoplasms, Plasma Cell
74
Recurrence
70
Lymphoma
57
Leukemia
54
Neoplasms
46
Immunoglobulin Light-chain Amyloidosis
38
Burkitt Lymphoma
37
Vomiting
36
Lymphoma, Mantle-Cell
32
Lymphoma, Large B-Cell, Diffuse
31
Nausea
29
Lymphoma, Non-Hodgkin
28
Breast Neoplasms
22
Waldenstrom Macroglobulinemia
21
Lymphoma, Follicular
21
Hodgkin Disease
21
Leukemia, Lymphocytic, Chronic, B-Cell
20
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
17
Neoplasm Metastasis
17
Prostatic Neoplasms
16
Lymphoma, Extranodal NK-T-Cell
16
Amyloidosis
16
Leukemia, Myeloid, Acute
15
Smoldering Multiple Myeloma
14
Lymphoma, B-Cell, Marginal Zone
13
Lung Neoplasms
11
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
10
Lymphoma, B-Cell
10
Interventions
Metformin
7
Progesterone
6
Spironolactone
4
drospirenone and ethinyl estradiol combination
3
Inositol
3
Ethinyl Estradiol
3
salicylsalicylic acid
2
Sugars
2
Folic Acid
2
Flutamide
2
Estradiol
2
Cyproterone Acetate
2
maltodextrin
1
bicalutamide
1
Yoga
1
Waist-Hip Ratio
1
Waist Circumference
1
Ultrasonography
1
Topiramate
1
Time
1
Thioctic Acid
1
Sodium Salicylate
1
Sex Characteristics
1
Physical Examination
1
Phlebotomy
1
Phenotype
1
Ovidrel
1
Magnesium
1
Lactalbumin
1
Inulin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hyperandrogenism
×
Dexamethasone
×
Clear all
NCT01421810
2023-10-27
CBS001
University of Virginia
Phase NA
Unknown
80 enrolled